Background: Primary focal dystonia (PFD) is characterized by motor symptoms.
Lencer 7 means [12] by computing effect size estimates of key measures as a descriptive approach using Cohen's d procedure. [13] 
Statistical analysis
Prevalence rates of DSM-IV axis I disorders in the PFD sample were compared by logistic regression analysis to those of a representative sample consisting of 3, 943 individuals between 18-64 years randomly drawn from registration office files of the general population in Northern Germany. [14] Comparable to the SCID, the control sample was evaluated by a personal interview for establishing all relevant psychiatric axis I diagnosis according to the DSM-IV, i.e. the "Munich Composite International Diagnostic Interview" (M-CIDI). [15] Clinical reappraisal studies have shown that CIDI-SCID agreement in DSM-lV diagnoses is generally good. [16] To adapt both samples, only PFD patients younger than 65 years (N=57) were included. Sex and age were implemented as independent variables, and each of the psychiatric disorders as dependent variables to calculate odds ratios with 95% confidence intervals. We used the Breslow-Day Test to test for homogeneity of odds ratios. [17] The prevalence rates for personality disorders were compared by Chi-square tests to those of a population-based random sample based on 2,053 subjects (1,142 men, 911 women) from Northern Europe (18-64 years) selected for the evaluation of DSM-IV personality disorders. [18] Lencer 8 Although all patients were successfully treated with botulinum toxin, the chance to develop secondary social phobia was extremely high. Social phobia has been shown to be even more common in PFD than in other possibly stigmatizing disorders such as alopecia areata, thus unlikely being a mere consequence of disfigurement. [2] Development of secondary social phobia may have been facilitated by the pronounced personality traits revealed by the NEO-FFI, implying that PFD patients have difficulties in coping with dystonia symptoms and thus avoid social situations and being evaluated by others.
Increased chances for alcohol abuse and drug dependence in men may be a consequence of the fact that motor symptoms in dystonia are often relieved by alcohol, benzodiazepine or anticholinergic drugs. [20] Interestingly, results from genetic studies suggest that there may be an additional neurobiological factor predisposing to substance-related disorders in PFD. [21, 22] 
Neurobiological basis for motor and psychiatric symptoms in PFD
A dysfunction of basal ganglia-thalamo-cortical circuits has been assumed to underlie both motor and psychiatric symptoms. [7] The link between networks subserving mental and motor functions may be provided by direct affective input to the caudate nucleus and the thalamus originating from the amygdale and the orbitofrontal Lencer 13
cortex. [23] It is conceivable that in a disorder such as PFD, disturbed neural activity in motor loops linking the basal ganglia via the thalamus to the frontal cortex may also have an influence on the so-called limbic loops which mediate attentional, cognitive and limbic functions resulting in both altered motor and affective processing. [24] Genetic factors may be another shared neurobiological basis. There is a range of inherited movement disorders where psychiatric disorders are part of the phenotypic spectrum of the genetic mutation. [25] In myoclonus-dystonia, higher rates of obsessive-compulsive disorder and alcohol dependence were found in SGCE mutation carriers. [21, 22] This example illustrates that psychiatric disorders may be linked to the same genetic abnormality that is associated with a distinct movement disorder.
Limitations
We cannot exclude a selection bias due to the fact that only PFD patients agreeing to botulinum toxin treatment were recruited and that they may have scored higher on agreeableness than those who refused, which is a general limitation of clinical studies. Based on the assumption that different dystonia subtypes share common aetiological factors, [26] we did not intend to make any statement with respect to specific neuropsychiatric features of specific PFD subgroups or differences between PFD subgroups. In fact, a high phenotypic variability has been observed even within families with multiples cases of dystonia. Further studies with larger sample sizes of subgroups may be able to answer this question.
In conclusion, the results of the present study expand earlier findings showing more specifically that anxiety spectrum disorders represent part of the phenotypic PFD Lencer 14 spectrum. Interdisciplinary research effort is needed to unravel the shared disease mechanisms of both motor and neuropsychiatric symptoms in PFD with highresolution imaging and genetic approaches being most promising. Distinct symptoms may be associated with specific alterations of limbic and frontal circuitry. [27] Lencer 18 ** Large effect size of ≥ 0.8 according to Cohen [13] 
Legend

